Brief: Interpace Announces Study With University Of North Carolina To Assess Use Of Barregen
Jan 6 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES ANNOUNCES COLLABORATIVE STUDY WITH
UNIVERSITY OF NORTH CAROLINA TO ASSESS THE USE BARREGEN® AFTER
ABLATION OF DYSPLASTIC BARRETT’S ESOPHAGUS
* INTERPACE BIOSCIENCES - STUDY EXPECTED TO BEGIN ENROLLING
PATIENTS EARLY IN Q1 2020 WITH HOPE OF READOUT LATER IN YEAR
Source text for Eikon: ID:nGNXbSFg2L
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million